#6 - Intuitive Surgical (NASDAQ:ISRG)
Intuitive Surgical (NASDAQ:ISRG) is one of the holding in the ARK Autonomous Technology & Robotics Fund (NYSEARCA:ARKQ). Intuitive Surgical is the recognized leader in robotic surgery. The stock has climbed over 276% in the last five years. And for much of that time, except for the big dip the stock took at the onset of the pandemic, the stock’s trajectory has been bullish.
When the pandemic hit, hospitals had to postpone elective surgeries. But since last summer, those procedures are coming back on line and so is investor interest in ISRG stock. The company has a strong balance sheet that contains no debt and as of the company’s last earnings report showed $4.7 billion in cash. And the company has a business model that allows it to generate income from its customers even after they have invested in the company’s robotic surgical equipment.
Since its pandemic low of $367.75, the stock has climbed 98% and the company appears to be generating revenue and earnings that are near pre-pandemic levels. Analysts have a consensus hold rating on Intuitive Surgical, but recent price targets suggest the stock can go much higher.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More - Current Price
- $547.87
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 14 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $524.61 (4.2% Downside)
